| Code | Description | Claims | Beneficiaries | Total Paid |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
8,708 |
4,230 |
$3.16M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
54,155 |
45,849 |
$1.99M |
| 81001 |
|
32,828 |
29,108 |
$1.70M |
| 80053 |
Comprehensive metabolic panel |
39,528 |
33,304 |
$1.40M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,767 |
10,896 |
$1.09M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,451 |
10,177 |
$1.01M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
30,648 |
9,056 |
$963K |
| 36415 |
Collection of venous blood by venipuncture |
13,834 |
11,738 |
$945K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
17,876 |
5,634 |
$898K |
| 81025 |
|
16,904 |
15,408 |
$833K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,847 |
9,310 |
$731K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,235 |
5,881 |
$715K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
22,388 |
17,569 |
$651K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,328 |
4,939 |
$615K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,668 |
3,461 |
$546K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,907 |
9,639 |
$506K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,236 |
17,312 |
$456K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,046 |
4,160 |
$453K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
12,089 |
4,592 |
$415K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
35,504 |
29,571 |
$406K |
| 87081 |
|
4,338 |
4,075 |
$391K |
| 93970 |
|
1,882 |
1,786 |
$305K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,459 |
3,388 |
$281K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,210 |
8,390 |
$270K |
| 87070 |
|
1,042 |
947 |
$249K |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,226 |
9,417 |
$241K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,668 |
918 |
$233K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,864 |
3,530 |
$230K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,831 |
1,767 |
$193K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
219 |
213 |
$188K |
| 71046 |
Radiologic examination, chest; 2 views |
9,877 |
9,275 |
$186K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,330 |
1,231 |
$163K |
| 86850 |
|
3,152 |
2,890 |
$163K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,665 |
4,381 |
$154K |
| D1120 |
Prophylaxis - child |
1,688 |
1,329 |
$143K |
| 74018 |
|
1,983 |
1,872 |
$139K |
| 73130 |
|
2,039 |
1,898 |
$137K |
| 71250 |
|
1,071 |
1,046 |
$135K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22,929 |
19,459 |
$135K |
| 93880 |
|
715 |
680 |
$130K |
| 77336 |
|
619 |
217 |
$129K |
| 97161 |
|
2,760 |
2,667 |
$122K |
| 73630 |
|
2,681 |
2,474 |
$120K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,476 |
4,396 |
$119K |
| 83735 |
|
11,726 |
9,355 |
$116K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
923 |
885 |
$115K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
437 |
414 |
$113K |
| 86900 |
|
4,650 |
4,230 |
$109K |
| 73610 |
|
2,034 |
1,912 |
$109K |
| 93922 |
|
592 |
586 |
$104K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,193 |
4,874 |
$103K |
| 94060 |
|
314 |
312 |
$99K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,912 |
4,695 |
$97K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,461 |
2,234 |
$93K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,272 |
1,208 |
$89K |
| 71045 |
Radiologic examination, chest; single view |
17,525 |
15,419 |
$87K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,190 |
1,920 |
$87K |
| 76642 |
|
2,134 |
1,906 |
$84K |
| 73564 |
|
2,352 |
2,118 |
$82K |
| 73030 |
|
2,166 |
1,989 |
$77K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24,941 |
21,867 |
$73K |
| G0378 |
Hospital observation service, per hour |
9,755 |
6,590 |
$69K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,169 |
4,846 |
$66K |
| 94664 |
|
729 |
518 |
$63K |
| 80069 |
|
2,031 |
1,281 |
$61K |
| 82962 |
|
2,192 |
953 |
$59K |
| 97162 |
|
1,429 |
1,369 |
$59K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,784 |
11,053 |
$59K |
| 73110 |
|
1,131 |
1,048 |
$58K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,583 |
3,339 |
$56K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,774 |
8,497 |
$54K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,162 |
1,110 |
$53K |
| 77065 |
Tomosynthesis, mammo |
1,422 |
1,315 |
$52K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,056 |
3,824 |
$51K |
| 10060 |
|
132 |
125 |
$50K |
| 72100 |
|
1,793 |
1,711 |
$50K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,625 |
6,937 |
$49K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,817 |
1,728 |
$48K |
| 88304 |
|
936 |
911 |
$47K |
| 93925 |
|
827 |
792 |
$46K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,276 |
2,162 |
$42K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,017 |
961 |
$42K |
| 92523 |
|
358 |
349 |
$38K |
| 76770 |
|
502 |
485 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
56,142 |
45,013 |
$36K |
| 85027 |
|
6,544 |
4,830 |
$35K |
| 12001 |
|
244 |
232 |
$35K |
| 87210 |
|
2,144 |
2,007 |
$32K |
| 20610 |
|
308 |
261 |
$32K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
671 |
572 |
$28K |
| 73502 |
|
1,331 |
1,248 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,907 |
4,607 |
$27K |
| 97116 |
|
1,324 |
560 |
$27K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,696 |
1,436 |
$26K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
3,668 |
1,160 |
$25K |
| 84702 |
|
4,890 |
3,623 |
$24K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
889 |
797 |
$24K |
| 87077 |
|
1,995 |
1,878 |
$24K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
89 |
80 |
$23K |
| 84112 |
|
107 |
96 |
$23K |
| 73140 |
|
197 |
183 |
$22K |
| 76536 |
|
308 |
292 |
$21K |
| 97165 |
|
647 |
608 |
$21K |
| 76801 |
|
399 |
373 |
$21K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,307 |
1,445 |
$20K |
| 70486 |
|
504 |
481 |
$20K |
| 93798 |
|
660 |
135 |
$20K |
| 81003 |
|
1,596 |
1,537 |
$18K |
| 59025 |
Fetal non-stress test |
2,990 |
2,235 |
$17K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,115 |
986 |
$17K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,657 |
2,326 |
$17K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
82 |
81 |
$17K |
| 87807 |
|
1,126 |
1,060 |
$16K |
| J3490 |
Unclassified drugs |
7,129 |
4,838 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,153 |
4,286 |
$16K |
| 77066 |
Tomosynthesis, mammo |
189 |
182 |
$15K |
| 96376 |
|
5,942 |
3,570 |
$15K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,673 |
2,538 |
$15K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
543 |
523 |
$15K |
| 12011 |
|
109 |
103 |
$15K |
| D0120 |
Periodic oral evaluation - established patient |
614 |
409 |
$14K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,804 |
3,721 |
$14K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
377 |
350 |
$14K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
8,727 |
7,698 |
$13K |
| 77386 |
|
302 |
12 |
$13K |
| 73080 |
|
187 |
177 |
$13K |
| D0220 |
Intraoral - periapical first radiographic image |
900 |
497 |
$12K |
| 11045 |
|
1,198 |
710 |
$12K |
| D0272 |
Bitewings - two radiographic images |
1,321 |
823 |
$12K |
| 62323 |
|
241 |
225 |
$11K |
| 73090 |
|
244 |
237 |
$11K |
| 86922 |
|
264 |
231 |
$11K |
| 73562 |
|
367 |
323 |
$10K |
| D0240 |
|
437 |
294 |
$9K |
| 85610 |
|
13,152 |
11,582 |
$9K |
| 87631 |
|
233 |
193 |
$9K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
4,164 |
1,110 |
$9K |
| 88307 |
|
232 |
209 |
$8K |
| 74178 |
|
42 |
41 |
$8K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
33 |
27 |
$7K |
| 11043 |
|
17 |
15 |
$7K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,862 |
830 |
$7K |
| 72050 |
|
111 |
104 |
$7K |
| 72040 |
|
90 |
89 |
$7K |
| 86140 |
|
1,442 |
1,216 |
$6K |
| 76830 |
Ultrasound, transvaginal |
84 |
79 |
$6K |
| 12002 |
|
27 |
25 |
$6K |
| 73590 |
|
233 |
208 |
$6K |
| 97750 |
|
736 |
635 |
$6K |
| 88342 |
|
112 |
106 |
$5K |
| D2330 |
|
2,060 |
805 |
$5K |
| 70496 |
|
42 |
40 |
$5K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
15 |
14 |
$5K |
| 72131 |
|
446 |
432 |
$5K |
| 85379 |
|
1,967 |
1,846 |
$5K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
13 |
13 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
77 |
65 |
$5K |
| 73560 |
|
156 |
132 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
338 |
305 |
$4K |
| 85730 |
|
11,088 |
10,021 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,144 |
324 |
$4K |
| 82570 |
|
1,664 |
1,446 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
117 |
105 |
$4K |
| A4648 |
Tissue marker, implantable, any type, each |
30 |
27 |
$4K |
| 97597 |
|
104 |
61 |
$4K |
| 94726 |
|
421 |
418 |
$4K |
| G0239 |
Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring) |
137 |
27 |
$4K |
| 76000 |
|
89 |
83 |
$3K |
| 82731 |
|
14 |
13 |
$3K |
| 87088 |
|
4,083 |
3,733 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
1,663 |
756 |
$3K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,986 |
825 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,119 |
5,096 |
$3K |
| 94644 |
|
1,603 |
1,408 |
$3K |
| 80177 |
|
408 |
338 |
$3K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
31 |
25 |
$3K |
| G0379 |
Direct admission of patient for hospital observation care |
832 |
714 |
$3K |
| 82550 |
|
7,860 |
6,646 |
$3K |
| 88142 |
|
207 |
205 |
$3K |
| 84145 |
|
1,068 |
917 |
$3K |
| 93971 |
|
29 |
28 |
$2K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
142 |
132 |
$2K |
| 93976 |
|
1,484 |
1,385 |
$2K |
| 78451 |
|
14 |
13 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,728 |
620 |
$2K |
| 84484 |
|
14,836 |
11,852 |
$2K |
| 72141 |
|
14 |
12 |
$2K |
| 82803 |
|
270 |
240 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,264 |
2,084 |
$2K |
| 82272 |
|
238 |
224 |
$2K |
| 82805 |
|
389 |
329 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,655 |
2,103 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,138 |
8,868 |
$2K |
| 83880 |
|
6,126 |
5,338 |
$2K |
| 80176 |
|
32 |
28 |
$2K |
| 97166 |
|
28 |
25 |
$2K |
| 77334 |
|
19 |
13 |
$2K |
| D7140 |
Extraction, erupted tooth or exposed root |
1,333 |
493 |
$2K |
| 77001 |
|
90 |
74 |
$2K |
| 92522 |
|
30 |
28 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
25 |
20 |
$1K |
| 70491 |
|
13 |
12 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,931 |
6,516 |
$1K |
| 82077 |
|
3,636 |
3,162 |
$1K |
| 36600 |
|
56 |
44 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
544 |
445 |
$1K |
| 80076 |
|
2,721 |
2,481 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
16 |
14 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,789 |
3,064 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
15 |
13 |
$1K |
| 36430 |
|
182 |
153 |
$984.55 |
| 72114 |
|
14 |
14 |
$916.52 |
| 82728 |
|
204 |
173 |
$855.78 |
| 97535 |
Self-care/home management training, each 15 minutes |
335 |
203 |
$826.74 |
| 76775 |
|
15 |
14 |
$797.10 |
| 75984 |
|
282 |
251 |
$735.53 |
| 82951 |
|
26 |
26 |
$714.43 |
| 92610 |
|
12 |
12 |
$696.89 |
| 71101 |
|
12 |
12 |
$645.46 |
| 80061 |
Lipid panel |
1,835 |
1,708 |
$638.83 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
217 |
183 |
$629.40 |
| A9270 |
Non-covered item or service |
8,903 |
4,653 |
$602.84 |
| 93978 |
|
52 |
52 |
$586.93 |
| 86901 |
|
4,649 |
4,231 |
$583.37 |
| 80164 |
|
201 |
168 |
$578.97 |
| 83690 |
|
12,455 |
11,107 |
$564.91 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,531 |
5,937 |
$531.78 |
| 87186 |
|
3,317 |
3,054 |
$475.84 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
15 |
14 |
$445.16 |
| 83540 |
|
438 |
409 |
$434.66 |
| 82150 |
|
955 |
876 |
$400.23 |
| 51702 |
|
43 |
39 |
$395.55 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
3,639 |
1,403 |
$373.55 |
| 84100 |
|
1,526 |
1,097 |
$366.90 |
| C2627 |
Catheter, suprapubic/cystoscopic |
15 |
14 |
$353.60 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
831 |
803 |
$280.14 |
| 99215 |
Prolong outpt/office vis |
34 |
32 |
$270.14 |
| 82042 |
|
139 |
124 |
$261.57 |
| 97168 |
|
65 |
53 |
$247.79 |
| 93000 |
|
114 |
107 |
$246.44 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,087 |
865 |
$234.02 |
| C1769 |
Guide wire |
342 |
320 |
$221.42 |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
15 |
15 |
$211.51 |
| 90715 |
|
942 |
912 |
$199.63 |
| 86318 |
|
865 |
810 |
$193.39 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
211 |
202 |
$192.71 |
| 97164 |
|
164 |
137 |
$188.81 |
| 85018 |
|
97 |
81 |
$186.52 |
| 77300 |
|
17 |
14 |
$167.18 |
| 87040 |
|
2,494 |
2,221 |
$152.36 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
349 |
337 |
$143.31 |
| 82746 |
|
43 |
39 |
$140.09 |
| 70498 |
|
55 |
52 |
$139.91 |
| 82607 |
|
165 |
136 |
$115.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,414 |
1,309 |
$111.52 |
| 84439 |
|
882 |
852 |
$89.61 |
| 51705 |
|
303 |
264 |
$81.13 |
| 82247 |
|
21 |
12 |
$77.55 |
| 82330 |
|
39 |
30 |
$70.49 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
157 |
156 |
$66.42 |
| 83605 |
|
2,780 |
2,417 |
$64.15 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,583 |
5,122 |
$63.29 |
| 87205 |
|
963 |
879 |
$60.99 |
| 83655 |
|
12 |
12 |
$48.04 |
| 85652 |
|
367 |
319 |
$34.86 |
| 93017 |
|
108 |
106 |
$32.31 |
| 84436 |
|
1,523 |
1,398 |
$32.18 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
513 |
483 |
$29.60 |
| 84156 |
|
1,986 |
1,626 |
$27.06 |
| 84550 |
|
926 |
796 |
$25.48 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
409 |
401 |
$23.54 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
512 |
504 |
$19.03 |
| 82553 |
|
1,635 |
1,431 |
$15.45 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
701 |
599 |
$14.18 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,114 |
2,438 |
$11.30 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,140 |
934 |
$10.74 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
365 |
286 |
$8.93 |
| 80179 |
|
238 |
225 |
$7.49 |
| 80143 |
|
329 |
309 |
$7.49 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,759 |
1,613 |
$5.96 |
| J2060 |
Injection, lorazepam, 2 mg |
1,175 |
888 |
$5.22 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,709 |
2,545 |
$2.63 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
57 |
48 |
$0.00 |
| 82575 |
|
116 |
102 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,830 |
2,696 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
1,434 |
1,098 |
$0.00 |
| D2931 |
|
1,868 |
565 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
104 |
88 |
$0.00 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
912 |
874 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
197 |
193 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
240 |
232 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
37 |
24 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
387 |
255 |
$0.00 |
| D2331 |
|
1,378 |
489 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
107 |
106 |
$0.00 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
608 |
307 |
$0.00 |
| 94618 |
|
37 |
37 |
$0.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
3,666 |
482 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
199 |
185 |
$0.00 |
| D1351 |
Sealant - per tooth |
67 |
25 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
27 |
25 |
$0.00 |
| 86780 |
|
14 |
14 |
$0.00 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
28 |
25 |
$0.00 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
16 |
14 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
204 |
111 |
$0.00 |
| 88341 |
|
15 |
14 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
221 |
210 |
$0.00 |
| 86920 |
|
70 |
61 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
66 |
64 |
$0.00 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
13 |
12 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
19 |
12 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
14 |
13 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
14 |
13 |
$0.00 |
| 82952 |
|
25 |
25 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
13 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |
| D0273 |
|
25 |
13 |
$0.00 |
| 85045 |
|
1,880 |
1,300 |
$0.00 |
| D2932 |
|
887 |
329 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
4,742 |
3,668 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
535 |
508 |
$0.00 |
| 51701 |
|
153 |
141 |
$0.00 |
| D0274 |
Bitewings - four radiographic images |
263 |
149 |
$0.00 |
| 82010 |
|
777 |
700 |
$0.00 |
| 84466 |
|
332 |
303 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
77 |
63 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
174 |
171 |
$0.00 |
| 82009 |
|
315 |
280 |
$0.00 |
| 94729 |
|
348 |
347 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
220 |
181 |
$0.00 |
| 76937 |
|
85 |
77 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
146 |
122 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
71 |
67 |
$0.00 |
| P9021 |
Red blood cells, each unit |
132 |
103 |
$0.00 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
141 |
137 |
$0.00 |
| 96367 |
|
65 |
53 |
$0.00 |
| 80074 |
|
12 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
88 |
63 |
$0.00 |
| D2332 |
|
321 |
133 |
$0.00 |
| 85014 |
|
33 |
24 |
$0.00 |
| 83970 |
|
26 |
25 |
$0.00 |
| 94645 |
|
12 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
187 |
151 |
$0.00 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
80 |
76 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
48 |
28 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
13 |
12 |
$0.00 |
| D2150 |
Silver amalgam - two surfaces, primary or permanent |
24 |
12 |
$0.00 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
60 |
50 |
$0.00 |
| A4311 |
Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
54 |
52 |
$0.00 |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
12 |
12 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
13 |
12 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
18 |
17 |
$0.00 |